...
首页> 外文期刊>British Journal of Pharmacology >Cibenzoline, an ATP-sensitive K~+ channel blocker, binds to the K~+ -binding site from the cytoplasmic side of gastric H~+, K~+, -ATPase
【24h】

Cibenzoline, an ATP-sensitive K~+ channel blocker, binds to the K~+ -binding site from the cytoplasmic side of gastric H~+, K~+, -ATPase

机译:ATP敏感性K〜+通道阻滞剂Cibenzoline从胃H〜+,K〜+,-ATPase的细胞质侧结合到K〜+结合位点

获取原文
获取原文并翻译 | 示例
           

摘要

Cibenzoline,(±)-2-(2,2-diphenylcyclopropyl-2-imidazoline succinate, has been clinically used as one of the Class I type antiarrhythmic agents and also reported to block ATP-ensitive K~+ channels in excised membranes from heart and pancreaticβcells. In the present study, we investigated if this drug inhibited gastric H~+, K~+ -ATPase activity in vitro. Cibenzoline inhibited H~+, K~+ -ATPase activity of permeabilized leaky hog gastric vesicles in a Concentration-dependent manner(IC_50: 201μM), whereas no effect was shown on Na~+, K~+ -ATPase Activity of dog kidney(IC_50: > 1000μM).
机译:环苯甲酸(±)-2-(2,2-二苯基环丙基-2-咪唑啉琥珀酸酯)已被临床用作I类抗心律不齐药物之一,并且据报道还可以阻断心脏切除的膜中的ATP敏感性K〜+通道。在本研究中,我们研究了该药物在体外是否能抑制胃中的H〜+,K〜+ -ATPase活性; Cibenzoline在浓度集中抑制通透性漏出的猪胃小泡的H〜+,K〜+ -ATPase活性。依赖的方式(IC_50:>1000μM)(IC_50:>201μM),而对狗肾的Na〜+,K〜+ -ATPase活性没有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号